NIAID Funding News, April 6, 2016
April 6, 2016 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Feature Articles
Give Your Application a Second Chance With OnPAR
If your meritorious application misses NIH's payline, a new private-public partnership pilot called Online Partnership to Accelerate Research (OnPAR) could offer a second chance to receive funding.
Opportunities and Resources
Don’t Overlook Ongoing R01 Immunology Grant Opportunity
You may not have realized: The funding opportunity announcement High-Priority Immunology Grants, which we issued in FY 2015 to encourage more applications in high-priority areas of immunology, did not expire!
For HIV Researchers: A Funding Opportunity on Eliminating the Latent HIV Reservoir
Consider responding to a reissued U01 funding opportunity announcement if you are an investigator who can design a clinical trial to test interventions aimed at eliminating latently-infected cells containing replication competent HIV provirus.
Improve Immunity in Neonates and Infants
NIH invites applications for a reissued U01 funding opportunity announcement that seeks to ultimately improve infant and neonatal immunity.
Contractors: Check Out a Solicitation for Preclinical Development Support
Through a recent request for proposals, NIAID seeks proposals on preclinical development support for promising products that emerge from investigator-initiated research studies.
In The News
Submit Feedback on Clinical Trial Protocol Template
NIH and FDA recently published a draft template with instructional and sample text for NIH-funded investigators to use when writing a protocol for phase 2 or 3 clinical trials that require investigational new drug or investigational device exemption applications.
News Briefs
- Register for NIH Regional Seminar Before Rates Increase on Friday
- See Updated Guidelines for Research With Recombinant or Synthetic Nucleic Acid Molecules
- New FORMS-D Application Instructions Clarify Biosketch Requirements
Advice Corner
Accounting for Other Sources of Funding in Your Grant Application
When you’re ready to submit your next application for an NIH grant, how should you account for other support?
Reader Questions
- Will there be a penalty to the institution or principal investigator if the investigator takes retirement before fully completing a project and the left-over funds are returned to NIH?
- I am a site leader for a multicenter U34 grant but not the program director for the entire project. Does this disqualify me as a new investigator for future R01 applications?
New Funding Opportunities
- RFP-NIAID-DAIDS-NIHAI2015055,
External Quality Assurance Program Oversight Laboratory - PA-16-163, Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program
- PA-16-162, NIH Small Research Grant Program (Parent R03)
- PA-16-161, NIH Exploratory/Developmental Research Grant Program (Parent R21)
- PA-16-160, NIH Research Project Grant (Parent R01)
- RFA-AI-16-034, Partnerships for Countermeasures Against Select Pathogens
- RFA-AI-16-025, Prevention Innovation Program III (PIP)
- PA-16-152, Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
- PA-16-151, Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario